$1.42-0.01 (-0.70%)
American Shared Hospital Services provides technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services.
American Shared Hospital Services in the Healthcare sector is trading at $1.42 with a market capitalization of $11M. Wall Street consensus targets $4.00 (1 analysts), implying a +181.7% move over the next 12 months. The stock is currently near its 52-week low of $1.25, remaining 19.3% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $7.08Mβ | $7.73Mβ | $7.17Mβ | $7.07Mβ | $6.11M |
| Gross Profit | $1.29Mβ | $906,000β | $1.59Mβ | $1.63Mβ | $942,000 |
| Operating Income | -$622,000β | -$1.08Mβ | $48,000β | -$116,000β | -$866,000 |
| Net Income | -$612,000β | -$631,000β | -$17,000β | -$280,000β | -$625,000 |
American Shared Hospital Services provides technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services. It operates in two segments: Leasing and Direct Patient Service. The company leases nine Gamma Knife ...

Direct patient services revenue jumped 40% year over year in Q2.
AMS reports 19% revenue surge and improved cash flow, while navigating credit agreement amendments and credit loss provisions.

Moby summary of American Shared Hospital Services's Q2 2026 earnings call
Recent share performance and context ams-OSRAM (SWX:AMS) has drawn attention after a recent daily gain of about 8.8%, adding to a 3.8% move over the past week and a small positive return over the past month. For investors tracking longer trends, the stock shows a very large gain over the past 3 months and a strong year to date return, while the 3 year and 5 year total returns reflect substantial declines over those periods. See our latest analysis for ams-OSRAM. For context, the latest...
AMS reports a 15.9% revenue increase and outlines plans for new facilities, despite ongoing net losses and higher operating costs.